<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00768677</url>
  </required_header>
  <id_info>
    <org_study_id>03-04-063</org_study_id>
    <nct_id>NCT00768677</nct_id>
  </id_info>
  <brief_title>Topiramate for Binge Eating Disorder Among Adolescents</brief_title>
  <official_title>Open-Label Study of Topiramate for Binge Eating Disorder and Bulimia Nervosa Among Adolescents</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Zucker Hillside Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Zucker Hillside Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a study of topiramate to see whether topiramate decreases binge eating behavior among
      adolescents and young adults. The investigators did also checked whether topiramate affected
      cognitive function or not.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2003</start_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
  </study_design_info>
  <condition>Eating Disorders</condition>
  <condition>Bulimia Nervosa</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>topiramate</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Subjects (aged 12 to 23) were included if they

          -  Met the criteria of bulimia nervosa or eating disorder NOS with binge-eating behavior
             in DSM-IV-TR,

          -  Had weight &gt; or = 100th % of expected body weight for their age,

          -  Engaged in binge eating at least once a week for 9 out of the 12 weeks prior to the
             study entry, and

          -  Were judged by a clinician to be stable enough to be treated for their psychiatric
             condition as an outpatient (i.e, no acute suicidality, hallucination, unstable vital
             signs or persistently abnormal laboratory results due to eating disorder).

        Exclusion Criteria:

          -  Subjects whose psychotropic medications had been changed within 4 weeks prior to the
             entry or who had started psychotherapy within 3 months prior to the entry were
             excluded.

          -  Subjects were also excluded if they were taking carbonic anhydrase inhibitors,
             carbamazepine, phenytoin, phenobarbital, valproic acid, evening primrose oil or oral
             contraceptives.

          -  Other exclusion criteria were: history of substance use disorders within the 6 months
             prior to study, IQ &lt; or = 70, medical conditions causing weight loss (i.e.,
             hyperthyroidism, diabetes mellitus type 1, malignancy) or that contra indicate
             treatment with topiramate (nephrolithiasis or glaucoma), history of non response or
             poor tolerance to topiramate in the past and history of non-adherence to medication
             treatment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>23 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>The Zucker Hillside Hospital</name>
      <address>
        <city>Glen Oaks</city>
        <state>New York</state>
        <zip>11004</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 7, 2008</study_first_submitted>
  <study_first_submitted_qc>October 7, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 8, 2008</study_first_posted>
  <last_update_submitted>October 7, 2008</last_update_submitted>
  <last_update_submitted_qc>October 7, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 8, 2008</last_update_posted>
  <responsible_party>
    <name_title>Ema Saito</name_title>
    <organization>The Zucker Hillside Hospital</organization>
  </responsible_party>
  <keyword>binge eating behavior</keyword>
  <keyword>adolescents</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Feeding and Eating Disorders</mesh_term>
    <mesh_term>Bulimia</mesh_term>
    <mesh_term>Binge-Eating Disorder</mesh_term>
    <mesh_term>Bulimia Nervosa</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Topiramate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

